» Articles » PMID: 35625858

High Expression of a TRNA Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence

Overview
Journal Biomedicines
Date 2022 May 28
PMID 35625858
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is the second most lethal cause of cancer-related deaths in Europe. Fragments of tRNA are conserved among vertebrates, characterized by pleiotropic regulatory functions and have been found to discriminate colorectal tumors from normal colorectal mucosa. In the current study, we investigated the prognostic utility of 5'-tiRNA-Pro levels in CRC. For this purpose, total RNA was extracted from 155 malignant colorectal tumors and 74 adjacent non-cancerous tissue specimens, polyadenylated and reverse-transcribed using an oligo-dT adapter as primer. Real-time quantitative PCR (qPCR) was used to assess the levels of 5'-tiRNA-Pro. Kaplan-Meier survival analysis demonstrated that high 5'-tiRNA-Pro levels predict both poor disease-free survival (DFS) and overall survival (OS) of CRC patients. Of note, high 5'-tiRNA-Pro levels retain their unfavorable prognostic value in patients with rectal cancer and/or moderately differentiated CRC (grade II). More importantly, multivariate cox regression analysis highlighted that the overexpression of 5'-tiRNA-Pro constitutes an adverse prognostic factor predicting short-term relapse of CRC patients independently of the established prognosticators in CRC. Finally, bioinformatics analysis unveiled a potentially critical role of 5'-tiRNA-Pro regarding the maintenance of cellular homeostasis, signaling, cell communication, and cellular motility.

Citing Articles

tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer.

Zhang B, Pan Y, Li Z, Hu K J Transl Med. 2025; 23(1):51.

PMID: 39806419 PMC: 11727791. DOI: 10.1186/s12967-025-06109-x.


Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).

Qiu W, Akanyibah F, Xia Y, Ocansey D, Mao F, Liang Y Int J Mol Med. 2024; 55(2).

PMID: 39704210 PMC: 11670865. DOI: 10.3892/ijmm.2024.5474.


tRNA-derived small RNAs (tsRNAs): establishing their dominance in the regulation of human cancer.

Gong L, Hu Y, Pan L, Cheng Y Front Genet. 2024; 15:1466213.

PMID: 39659673 PMC: 11628509. DOI: 10.3389/fgene.2024.1466213.


Research progress on the tsRNA biogenesis, function, and application in lung cancer.

Chen Y, Shao Z, Wu S Noncoding RNA Res. 2024; 10:63-69.

PMID: 39309197 PMC: 11414277. DOI: 10.1016/j.ncrna.2024.09.004.


Exploring the role of tRNA-derived small RNAs (tsRNAs) in disease: implications for HIF-1 pathway modulation.

Wang Q, Ying X, Huang Q, Wang Z, Duan S J Mol Med (Berl). 2024; 102(8):973-985.

PMID: 38850298 DOI: 10.1007/s00109-024-02458-0.


References
1.
Karousi P, Papanota A, Artemaki P, Liacos C, Patseas D, Mavrianou-Koutsoukou N . tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature. Biomedicines. 2021; 9(12). PMC: 8698603. DOI: 10.3390/biomedicines9121811. View

2.
Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R . Fast and effective prediction of microRNA/target duplexes. RNA. 2004; 10(10):1507-17. PMC: 1370637. DOI: 10.1261/rna.5248604. View

3.
Diamantopoulos M, Kontos C, Kerimis D, Papadopoulos I, Scorilas A . Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients. Clin Chem Lab Med. 2016; 55(5):737-747. DOI: 10.1515/cclm-2016-0756. View

4.
Sun C, Fu Z, Wang S, Li J, Li Y, Zhang Y . Roles of tRNA-derived fragments in human cancers. Cancer Lett. 2017; 414:16-25. DOI: 10.1016/j.canlet.2017.10.031. View

5.
Huang B, Yang H, Cheng X, Wang D, Fu S, Shen W . tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in Colorectal Cancer. Cancer Res. 2017; 77(12):3194-3206. DOI: 10.1158/0008-5472.CAN-16-3146. View